Kristi Jones - 11 Jun 2024 Form 4 Insider Report for NexImmune, Inc.

Role: President and CEO, Director
Signature: /s/John Rudy, attorney-in-fact
Issuer symbol: NEXI on OTC
Transactions as of: 11 Jun 2024
Net transactions value: +$0.01
Form type: 4
Filing time: 13 Jun 2024, 19:58:48 UTC
Previous filing: 06 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEXI	Series A Preferred Stock, par value $0.0001 per share	Purchase	$0.01	+1		$0.0100^*	1	11 Jun 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 11, 2024, the Reporting Person purchased one (1) share of Series A Preferred Stock, par value $0.0001 per share (the "Preferred Stock"), of NexImmune, Inc. (the "Issuer") from the Issuer for cash consideration of $0.01. The Preferred Stock has the rights, preferences, privileges and restrictions set forth in the Certificate of Designation of Series A Preferred Stock filed by the Issuer with the Secretary of State of the State of Delaware on June 11, 2024 (the "Series A COD"), including the right to have a number of votes equal to the number of outstanding shares of common stock,
F2	(Continued from footnote 1) par value $0.0001 per share ("Common Stock") on the record date for determining stockholders entitled to vote on such voting proposals defined in the Series A COD if the aggregate number of shares of Common Stock, present in person or by proxy and entitled to vote thereon that voted "for" a voting proposal is greater than the aggregate number of shares of Common Stock present in person or by proxy and entitled to vote thereon that voted "against" or "abstain" on such voting proposal.

Content

On June 11, 2024, the Reporting Person purchased one (1) share of Series A Preferred Stock, par value $0.0001 per share (the "Preferred Stock"), of NexImmune, Inc. (the "Issuer") from the Issuer for cash consideration of $0.01. The Preferred Stock has the rights, preferences, privileges and restrictions set forth in the Certificate of Designation of Series A Preferred Stock filed by the Issuer with the Secretary of State of the State of Delaware on June 11, 2024 (the "Series A COD"), including the right to have a number of votes equal to the number of outstanding shares of common stock,

(Continued from footnote 1) par value $0.0001 per share ("Common Stock") on the record date for determining stockholders entitled to vote on such voting proposals defined in the Series A COD if the aggregate number of shares of Common Stock, present in person or by proxy and entitled to vote thereon that voted "for" a voting proposal is greater than the aggregate number of shares of Common Stock present in person or by proxy and entitled to vote thereon that voted "against" or "abstain" on such voting proposal.